| | PCI with ECMO support (n = 14) | PCI with ECMO standby (n = 11) | value |
| Age, years (±SD) | 66.5 (±2.5) | 69.8 (±2.5) | 0.37 | Male, % (n) | 71.4 (10/14) | 72.7 (8/11) | 1.00 | Hypertension, % (n) | 42.9 (6/14) | 45.5 (5/11) | 1.00 | Diabetes mellitus, % (n) | 57.1 (8/14) | 45.5 (5/11) | 0.56 | Dyslipidaemia, % (n) | 28.6 (4/14) | 36.4 (4/11) | 1.00 | Congestive heart failure, % (n) | 57.1 (8/14) | 27.3 (3/11) | 0.23 | Prior MI, % (n) | 57.1 (8/14) | 63.6 (7/11) | 1.00 | Prior PCI, % (n) | 21.4 (3/14) | 36.3 (4/11) | 0.67 | Peripheral artery disease, % (n) | 28.6 (4/14) | 9.1 (1/11) | 0.34 | Lung disease, % (n) | 14.3 (2/14) | 27.3 (3/11) | 0.62 | Chronic kidney disease (GFR <30 ml/min), % (n) | 7.1 (1/14) | 18.2 (2/11) | 0.57 | Dialysis | 100 (1/1) | 100 (2/2) | | Three-vessel coronary artery disease, % (n) | 57.1 (8/14) | 54.5 (6/11) | 1.00 | Left main stenosis, % (n) | 78.6 (11/14) | 81.1 (9/11) | 1.00 | Generic bifurcation lesion, % (n) | 21.4 (3/14) | 36.4 (4/11) | 0.67 | CTO, % (n) | 71.4 (10/14) | 63.6 (7/11) | 1.00 | LVEF, % (±SD) | 33 (±3.0) | 36 (±4.6) | 0.54 | STS mortality risk score (± SD or IQR) | 2.9 (1.5–5.8) | 2.7 (±0.5) | 0.55 | SYNTAX score I (±SD) | 35.5 (±2.0) | 32.0 (±2.3) | 0.28 | SYNTAX score II (PCI) (±SD) | 49.8 (±3.2) | 51.5 (±3.7) | 0.74 | SYNTAX score II (CABG) (±SD) | 36.2 (±3.1) | 40.1 (±2.8) | 0.38 | Indication for MCS, % (n) | LM, SRC, or SMVD with severe LV-dysfunction | 57.1 (8/14) | | | LM, SRC, or SMVD with (recent) HF | 21.4 (3/14) | | | LM, SRC, or SMVD with expected technically challenging and prolonged PCI | 21.4 (3/14) | | | Preprocedural admission at ICU, % (n) | 7.1 (1/14) | 0 (0/11) | 1.00 |
|
|
CTO, chronic total occlusion; ECMO, extracorporeal membrane oxygenation; GFR, glomerular filtration rate; HF, heart failure; IQR, interquartile range; LM, left main; LVEF, left ventricular ejection fraction; MCS, mechanical circulatory support; MI, myocardial infarction; N, number of treated patients; PCI, percutaneous coronary intervention; SD, standard deviation; SMVD, severe multivessel disease; SRC, single remaining conduit.
|